Carmot Therapeutics is a startup based in the United States, most recent round Acquired.
Carmot Therapeutics is a company headquartered in the United States. Carmot Therapeutics has been acquired.
Carmot Therapeutics is a clinical-stage biotechnology company developing biased GLP-1 and GLP-1/GIP receptor agonists for the treatment of obesity and type 2 diabetes, with multiple assets (CT-868, CT-388, CT-996) in clinical trials. The company's website notes a definitive merger agreement for acquisition by Roche/Genentech.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.